Inventaire - i tuoi amici e le tue comunità sono la tua biblioteca

Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).

autore

Alison Goate

2000 -

A Joseph Bloom

Laura J. Bierut

Dorothy Hatsukami

Nancy L Saccone

Megan E Piper

pubblicato in: Addiction

data di pubblicazione: 2013-11-11

lingua: inglese

argomento principale: farmacoterapia

Cita articoli 34

Data

Titolo

Autori

2013-05-23

Individual patient data meta-analysis of diagnostic studies: opportunities and challenges

Gerben ter Riet, Khalid S Khan
2013-03-01

Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state

Rachel F. Tyndale
2013-02-01

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies

Pui-Yan Kwok, Andrew W Bergen, Caryn Lerman, David V Conti, Gary E Swan, Ruth Krasnow, Rachel F. Tyndale
2012-07-01

Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success

Stephanie M. Gogarten, Alison Goate, Naomi Breslau
2012-05-02

Reproducibility of the nicotine metabolite ratio in cigarette smokers

Rachel F. Tyndale
2012-09

PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6

Michelle Whirl-Carrillo, Ellen Mcdonagh, Russ Altman, Rachel F. Tyndale
2012-03-26

Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.

Grant W. Montgomery, Alison Goate, Nick Martin, A Joseph Bloom, Pamela A F Madden, Laura J. Bierut, Oscar Harari
2012-02-01

DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5.

Naomi Breslau
2012-07-01

The emerging potential of pharmacogenetics in psychiatry
2011-07-11

Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk

Rachel F. Tyndale, Margaret Spitz, Christopher Amos
2011-07-01

The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans

Alison Goate, A Joseph Bloom, Laura J. Bierut, Linda B von Weymarn, Evan D Kharasch
2010-08-05

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Marcella Rietschel, Maria Teresa Landi, Jaakko Kaprio, Joel Gelernter, Leena Peltonen-Palotie, Nilanjan Chatterjee, Sven Cichon, Richard Houlston, Richard Sherva, Peter Broderick, Grant W. Montgomery, Markus M. Nöthen, Nick Martin, Markku Heliövaara, Thomas J Payne, Xiangyang Kong, Kenneth Kendler, Xiangning Chen, David Hunter, Pamela A F Madden, Andrew C. Heath, Laura J. Bierut, Ina Giegling, Dan Rujescu, Margaret Spitz, Christopher Amos, Majken K Jensen, Naomi Breslau, Susan M Gapstur, Victoria L. Stevens, Neil Caporaso, Younghun Han, Nancy L Saccone, Robert C Culverhouse, Susan C Short, Angela S. Wenzlaff, Michele L Pergadia, Stephanie H Witt, Marissa A Ehringer, Ann G Schwartz, Victoria Sarah Stephen, Kaisu Keskitalo-Vuokko, Steven H Aggen, Mark Leppert, Tae-Hwi Schwantes-An, Shizhong Han, Jingchun Chen, Bao-Zhu Yang, Peter Kraft
2010-04-25

Genome-wide meta-analyses identify multiple loci associated with smoking behavior
2010-05

Meta-analysis and imputation refines the association of 15q25 with smoking quantity

Peter Vollenweider, Inês Barroso, Henry Völzke, David Schlessinger, Alexander Teumer, Claudia Lamina, Igor Rudan, Veronique Vitart, Martin Farrall, Manuela Uda, Paul Scheet, Anna Dominiczak, Vincent Mooser, Dan Rujescu, Jack Satsangi, Miles Parkes, Kay-Tee Khaw, Heinz Erich Wichmann, Anne Farmer, Ozren Polašek, Caroline Hayward, Gérard Waeber, Jane Worthington, Antonio Terracciano, Lina Zgaga, Jonathan Marchini, Fabio Busonero, Marcus Ising, James F. Wilson, Federica Tozzi, Clyde Francks, Keith Matthews, Ivana Kolcic, Mark Caulfield, Wendy Thomson, Muredach P. Reilly, Alistair Scott Hall, Ulrich John, Anne Barton, Christopher G. Mathew, Nilesh Samani, Carl A Anderson, Nicholas J. Wareham, Ruth J. Loos, Ron Waksman, Patricia B Munroe, Lowell F Satler, Augusto D. Pichard, Kenneth M Kent, Jaspal S Kooner, Dawn Waterworth, Peter McGuffin, Harry Campbell, Daniel Rader, Andre Franke, David St Clair, Christopher W Knouff, Mary Susan Burnett, William H Matthai, Hakon Hakonarson, Philip J. Barter, Jennifer E Huffman, Sarah H Wild, Gonçalo Abecasis, John F Thompson, Ruth McPherson, Lefkos T Middleton, Pierandrea Muglia, Martin Preisig, Antero Kesäniemi, Rajesh Rawal, Xiangjun Xiao, Hans Jörgen Grabe, Michael Wittig, Norbert Dahmen, Alan F Wright, Jing Hua Zhao, John Campbell Chambers, Scott M. Grundy
2010-04-25

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

Daniel F. Gudbjartsson, Tõnu Esko, Christian Gieger, Massimo Mangino, Inga Prokopenko, Reedik Mägi, Yurii S. Aulchenko, Nicole Soranzo, Henning Tiemeier, Cornelia M. van Duijn, Unnur Þorsteinsdóttir, Anke Tönjes, Solveig Gretarsdottir, Anna-Liisa Hartikainen, Samuli Ripatti, André Uitterlinden, Gonneke Willemsen, Anneli Pouta, Andres Metspalu, Angela Döring, Ida Surakka, Thorunn Rafnar, Maria Krestyaninova, Stefan Walter, Claire J. Steves, Thorgeir E. Thorgeirsson, Gregory T. Jones, Hreinn Stefansson, Najaf Amin, Ana M. Valdes, Alistair Scott Hall, Jes Lindholt, Grant W. Montgomery, Lambertus Kiemeney, Nick Martin, Jaakko Kaprio, Frank Geller, Martin den Heijer, Markus Perola, Veikko Salomaa, Brenda Penninx, Mark McCarthy, Nilesh Samani, Michael Stumvoll, Matti Isohanni, Albert Hofman, Jacqueline M Vink, Dorret Boomsma, Patrick Sulem, Leena Peltonen-Palotie, Kári Stefánsson, Jouke-Jan Hottenga, Pamela A F Madden, Andrew C. Heath, Ina Giegling, Dan Rujescu, Marjo-Riitta Järvelin, Heinz Erich Wichmann, Jaana Laitinen, Johannes Kettunen, Jeffrey Gulcher, Tim Spector, Nicole Vogelzangs, Peter Kovacs, Ben A Oostra, John F Thompson, Katja K H Aben, Mari Nelis, Norbert Dahmen, ENGAGE Consortium, Michele L Pergadia, Benjamin Dieplinger, Meinhard Haltmayer, Rajesh Rawal, Stefan E. Matthiasson, Hogni Oskarsson, Andre van Rij, Iris H. Gudjonsdottir, Barbara Nitz
2010-03-24

Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy

Rachel F. Tyndale
2009-11-01

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies
2009-01-23

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes

Caryn Lerman, Rachel F. Tyndale
2008-10-31

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study

Caryn Lerman, Rachel F. Tyndale
2008-09-01

Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers
2008-06

Molecular genetics of successful smoking cessation: convergent genome-wide association study results

Qing-Rong Liu, Sean P. David, Caryn Lerman
2008-04-02

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion

Larry Hawk, Rachel F. Tyndale
2007-09-01

Efficacy of bupropion alone and in combination with nicotine gum.

Daniel Bolt
2006-03-01

CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation

Yasushi Fujio
2006-05-11

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation

Rachel F. Tyndale
2005-09-01

Three haplotypes associated with CYP2A6 phenotypes in Caucasians

Ulrich M. Zanger
2004-09-01

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians

Edward M. Sellers, Rachel F. Tyndale
2004-08-12

Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.

Hiroshi Yamazaki, Maxwell Afari Gyamfi
2003-10-01

Nicotine metabolite ratio as a predictor of cigarette consumption

Cynthia S. Pomerleau, Ovide F. Pomerleau
2001-09-01

Measurement of self reported active exposure to cigarette smoke

Jean-Francois Etter
2000-10-01

Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity
1998-01-01

Overcoming the limitations of current meta-analysis of randomised controlled trials.

Articolo - wd:Q37625427

Benvenuto su Inventaire

la biblioteca dei tuoi amici e della tua comunità

ulteriori informazioni